Clinical Trials of America is committed to protecting the privacy of our patients.
This statement will explain CTA’s data collection and use practices with respect to its website (www.ctamerica.net; the “Site”). By using the pages in this site, you agree to the information collection and use practices described herein.
Collection of Personal Information
We may ask you for Personally Identifiable Information (PII) that allows us to contact you to provide a service or to carry out a transaction that you have requested, including requests for information about CTA’s serviced and requests for e-mail correspondence. The PII we collect may include your name, address, other contact information and other information about services requested through the Site.
Use of Personal Information
Except as otherwise required or permitted by law, the PII collected on this Site will solely be used to operate the Site and to provide the service(s) or to carry out the transaction(s) you have requested or authorized. In order to offer you a more consistent experience in your interactions with CTA, information collected by the Site may be combined with information collected in connection with other CTA services.
CTA may disclose PII if required to do so by law or in the good faith belief that such action is necessary to (a) conform to the edicts of the law or comply with legal process served on CTA or the Site or (b) protect and defend the rights or property of CTA and the Site.
Control of Personal Information
Except as otherwise described in this privacy statement, PII will not be shared outside of CTA and its subsidiaries and affiliates without your permission. You can access you PII and make choices about how you wish to be contacted by contacting CTA as described at the bottom of this statement or through alternative means of access described by the Site.
Security of Personal Information
CTA is strongly committed to protecting the security of your PII. We use a variety of security technologies to help protect PII from unauthorized access, use, or disclosure.
Changes to this statement
We reserve the right to update this privacy statement from time to time. We encourage you to review this privacy statement periodically to stay informed about how we are helping to protect the PII we collect. Your continued use of the service constitutes your agreement to this privacy statement, as amended from time to time.
Limitations of privacy statement
This privacy statement explains only data collection and use practices related to CTA’s website; it does not apply to other CTA services.
Coordination with terms and conditions
This privacy statement is intended solely to clarify CTA’s practices with respect to PII and shall not in any way modify or limit the legal effect of the Terms and Conditions with respect to the use of the Site.
CTA welcomes your comments regarding this privacy statement. If you believe that CTA has not adhered to this privacy statement, please contact us by telephone, email, or via postal mail at the following address. We will use commercially reasonable efforts to promptly determine and remedy the problem:
Clinical Trials of America-NC, LLC
210 Charlois Blvd, Suite 110
Winston-Salem, NC 27103